Loading...
PepGen Inc.
PEPG•NASDAQ
HealthcareBiotechnology
$1.50
$0.08(5.63%)
PepGen Inc. (PEPG) Financial Performance & Statements
Review PepGen Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
100.00%
↑ 100.00%
Net Income Growth
-14.44%
↓ 14.44%
Operating Cash Flow Growth
-19.38%
↓ 19.38%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-81.26%
↓ 81.26%
ROIC
-102.15%
↓ 102.15%
PepGen Inc. (PEPG) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for PepGen Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $370000.00 | $376000.00 |
| Gross Profit | $0.00 | $0.00 | -$370000.00 | -$376000.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $18.96M | $17.72M | $24.69M | $14.36M |
| SG&A Expenses | $5.38M | $5.45M | $5.36M | $5.07M |
| Operating Expenses | $24.34M | $23.17M | $30.05M | $19.42M |
| Total Costs & Expenses | $24.34M | $23.17M | $30.43M | $19.80M |
| Interest Income | $1.46M | $1.83M | $2.12M | $1.74M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.32M | $1.32M | $370000.00 | $376000.00 |
| EBITDA | -$23.03M | -$21.86M | -$30.05M | -$19.42M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$24.34M | -$23.17M | -$30.43M | -$19.80M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $1.49M | $1.79M | $2.09M | $1.78M |
| Income Before Tax | -$22.86M | -$21.38M | -$28.34M | -$18.02M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | -$617000.00 | $0.00 | $0.00 | $332724.00 |
| Net Income | -$22.24M | -$21.38M | -$28.34M | -$18.02M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.68 | -$0.66 | -$0.87 | -$0.63 |
| Diluted EPS | -$0.68 | -$0.66 | -$0.87 | -$0.63 |
| Weighted Avg Shares Outstanding | $32.60M | $32.58M | $32.47M | $28.66M |
| Weighted Avg Shares Outstanding (Diluted) | $32.60M | $32.58M | $32.47M | $28.66M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan